glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with ramiprilat in 1 studies
| Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (ramiprilat) | Trials (ramiprilat) | Recent Studies (post-2010) (ramiprilat) |
|---|---|---|---|---|---|
| 99 | 1 | 18 | 173 | 9 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaruzza, M; Hecker, M; Lauth, M | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and ramiprilat
| Article | Year |
|---|---|
ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; In Vitro Techniques; Irbesartan; Male; Peptide Fragments; Perfusion; Pressure; Rabbits; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptor, Endothelin B; Receptors, Angiotensin; Receptors, Bradykinin; Receptors, Endothelin; RNA, Messenger; Swine; Tetrazoles; Transfection; Vasoconstriction | 2001 |